| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/04/2007 | EP1534326B1 Improved bacterial outer membrane vesicles |
| 07/04/2007 | EP1357128B1 The preparation and usage of plasmodium fusion antigen |
| 07/04/2007 | EP1311699B1 Adeno-associated virus-mediated delivery of angiogenic factors |
| 07/04/2007 | EP1242823B1 Selecting library members capable of binding to epitopes |
| 07/04/2007 | EP1194560B1 Antigenic neisserial peptides |
| 07/04/2007 | EP1159427B1 Gp120 mutants and biological applications |
| 07/04/2007 | EP1082011B1 Avian polyomavirus vaccines in psittacine birds |
| 07/04/2007 | EP0958834B1 Use of peptide-based immunotherapeutic agent |
| 07/04/2007 | EP0942750B1 Anti-class ii mhc binding agents for use in xenotransplantation |
| 07/04/2007 | EP0935660B1 Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof |
| 07/04/2007 | EP0868435B1 High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein |
| 07/04/2007 | CN1993462A Adenoviral vector compositions |
| 07/04/2007 | CN1993145A Support system in the form of protein-based nanoparticles for the cell-specific enrichment of pharmaceutically active substances |
| 07/04/2007 | CN1993143A Method for treating multiple sclerosis |
| 07/04/2007 | CN1993142A Method for treating lupus |
| 07/04/2007 | CN1993141A Induction of an immune response against streptococcus pneumoniae polysaccharides |
| 07/04/2007 | CN1993140A Genetically engineered swine influenza virus and uses thereof |
| 07/04/2007 | CN1990874A Gene clone of hepatitis B virus front S1 region multi-epitope antigen and encoding sequence thereof |
| 07/04/2007 | CN1990870A Chicken infectivity bursa of Fabricius virus VP3 gene, expressed recombinant protein and application |
| 07/04/2007 | CN1990869A Chicken infectivity bursa of Fabricius virus VP2 cDNA, its expression vector, expressed recombinant protein and application thereof |
| 07/04/2007 | CN1990043A Use of recombinant human granulocyte macrophagocyte colony stimulating factor in preparation of drug for preventing and treating hepatitis B |
| 07/04/2007 | CN1990042A SARS coronary virus resistant cell vaccine and its uses |
| 07/04/2007 | CN1990041A Kidney syndrome hemorrhagic fever Vero cell bivalent purified vaccine and industrialized producing process thereof |
| 07/04/2007 | CN1990040A Strengthening vaccine kit for treating sarcoma and its application |
| 07/04/2007 | CN1324215C Emergency door opening system |
| 07/04/2007 | CN1324139C Vaccines |
| 07/04/2007 | CN1324049C Human source anti SARS coronavirus gene engineering antibody |
| 07/04/2007 | CN1323718C Process for preparing viral and bacterial vaccine for animals utilizing vegetable oil adjuvant |
| 07/04/2007 | CN1323716C Use of SAPR-1 for the treatment and/or prevention of scleroderma |
| 07/03/2007 | US7238800 Polynucleotides; generating antibodies; fungicide |
| 07/03/2007 | US7238786 For use in diagnosis and therapy |
| 07/03/2007 | US7238785 Antibody binding to glycoprotein; therapy, diagnosis of cancer |
| 07/03/2007 | US7238673 Genetic enginnering; kits |
| 07/03/2007 | US7238672 Nucleic acid sequence of genotype 1 (GT1) pasteur virus that consists of a sequence encoding amino acids 253-505 of GT1 pasteur virus glycoprotein; permits DNA vaccination without the need to supply multiple antigens on separate DNA molecules. |
| 07/03/2007 | US7238669 Phage-display peptides as novel antimicrobial agents against Haemophilus influenzae |
| 07/03/2007 | US7238667 Albumin fusion proteins |
| 07/03/2007 | US7238489 Identification of sortase gene |
| 07/03/2007 | US7238481 administering HETEROLOGOUS GENE PRODUCTS IN HOST CELL SYSTEMS AND/OR TO RESCUE NEGATIVE STRAND RNA RECOMBINANT VIRUSES |
| 07/03/2007 | US7238360 Getting the same result as gene therapy, without the introduction of exogenous DNA, by binding T cell with immunomodulator biotin, then contacting with avidin or streptavidin; apoptosis induction or resistance |
| 07/03/2007 | US7238359 A Proline-proline-glutamic acid family antigenic protein shows a strong B-cell immune response |
| 07/03/2007 | US7238358 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 07/03/2007 | US7238357 Methods for treating ulcers and gastroesophageal reflux disease |
| 07/03/2007 | US7238356 Core-glycosylated HCV envelope proteins |
| 07/03/2007 | US7238354 Method of treating atopic dermatitis using antibody against human interleukin-5 receptor alpha chain |
| 07/03/2007 | US7238353 Antibodies that recognize hyperproliferative cells and methods of making and using same |
| 07/03/2007 | US7238352 Methods and compositions for modulating tumor growth |
| 07/03/2007 | US7238349 Composition |
| 07/03/2007 | US7238347 Use of a mutant Leishmania responsive to external signals such as red or white light to become porphyric and commit suicidal cytolysis, immunizing a mammal |
| 07/03/2007 | US7238345 Nucleic acids and vectors; transformed host cells for expressing oligopeptides containing epitopes of use to immunize against meningococcal disease |
| 07/03/2007 | CA2361987C Goodpasture antigen binding protein |
| 07/03/2007 | CA2359177C Bhv-1 gene-deleted virus vaccine |
| 07/03/2007 | CA2256413C Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy |
| 07/03/2007 | CA2243302C Anti-human vegf receptor f1t-1 monoclonal antibody |
| 07/03/2007 | CA2174122C Therapeutic delivery compositions and methods of use thereof |
| 07/03/2007 | CA2158869C Recombinant virus, process for preparing the same and use thereof in gene therapy |
| 07/03/2007 | CA2092567C Nt-4 neurotrophic factor |
| 06/28/2007 | WO2007073137A1 Intranasal vaccine for use against disease caused by enterotoxigenic escherichia coli |
| 06/28/2007 | WO2007072977A1 Pharmaceutical composition for allergic disease |
| 06/28/2007 | WO2007072916A1 Vaccine for in ovo inoculation |
| 06/28/2007 | WO2007072866A1 Anti-ilt7 antibody |
| 06/28/2007 | WO2007072504A1 Dna vaccine for cancer therapy |
| 06/28/2007 | WO2007072070A1 New protein isoforms and uses thereof |
| 06/28/2007 | WO2007072032A2 Neisseria meningitidis vaccines and their use |
| 06/28/2007 | WO2007072022A2 Composition comprising an antigen-recognizing molecule and a lipid-based carrier |
| 06/28/2007 | WO2007071992A1 Casein-like secreted protein |
| 06/28/2007 | WO2007071986A1 Use of whole bacterial cells (actinomycetales) for maternal administration to modulate offspring immune response |
| 06/28/2007 | WO2007071982A1 Use of whole cell actinomycetales bacteria to treat stress-induced pulmonary haemorrhage |
| 06/28/2007 | WO2007071978A1 Method of producing rough strains of bacteria and uses thereof |
| 06/28/2007 | WO2007071839A2 Potentiation of apoptosis by monoclonal antibodies |
| 06/28/2007 | WO2007071786A2 Conjugate vaccines |
| 06/28/2007 | WO2007071711A2 Vaccine |
| 06/28/2007 | WO2007071710A2 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
| 06/28/2007 | WO2007071692A2 Immunogenic composition |
| 06/28/2007 | WO2007071426A1 Pharmaceutical compositions with resistance to soluble cea |
| 06/28/2007 | WO2007071390A1 Method for treating malignant melanoma |
| 06/28/2007 | WO2007071388A1 Improved method for expansion of tumour-reactive t-lymphocytes for immunotherapy of patients with cancer |
| 06/28/2007 | WO2007071051A1 Novel cancer-associated antigen |
| 06/28/2007 | WO2007070996A2 Liga and ligb proteins (leptospiral ig-like (lig) domains) for vaccination and diagnosis |
| 06/28/2007 | WO2007070983A1 Transdermal delivery of pharmaceutical agents |
| 06/28/2007 | WO2007070979A1 Chimeric antibodies with part new world primate binding regions |
| 06/28/2007 | WO2007070948A1 Anti-inflammatory dab |
| 06/28/2007 | WO2007051805A3 Use of ceacam8-specific substances for treating autoimmune diseases and a method for screening substances which induce apoptosis |
| 06/28/2007 | WO2007050607A3 Novel use of il-1beta compounds |
| 06/28/2007 | WO2007044756A3 Monoclonal antibodies recognizing human ccr8 |
| 06/28/2007 | WO2007040550A3 Torc polynucleotides and polypeptides, and methods of use |
| 06/28/2007 | WO2007028144A3 Immunoglobulins comprising predominantly a glcnacman3glcnac2 glycoform |
| 06/28/2007 | WO2007027713A3 Trail receptor 2 polypeptides and antibodies |
| 06/28/2007 | WO2007019232A3 Immunoconjugate formulations |
| 06/28/2007 | WO2007018843A3 Methods and compositions for diagnosis and treatment of influenza |
| 06/28/2007 | WO2007008690A3 Methods for monitoring neuroinflammatory destruction of neurons and for treating diseases having an inflammatory component related to phospholipase a2 |
| 06/28/2007 | WO2007005898A3 Blocking leukocyte emigration and inflammation by interfering with cd99l2 |
| 06/28/2007 | WO2006119516A3 Expression of viral proteins in plants |
| 06/28/2007 | WO2006113703A3 Carboline derivatives useful in the treatment of cancer |
| 06/28/2007 | WO2006099543A3 Methods for assessing antibody-mediated cytotoxicity |
| 06/28/2007 | WO2006093923B1 Treatment of bone disorders |
| 06/28/2007 | WO2006090385A3 Protease inhibitors and method of screening thereof |
| 06/28/2007 | WO2006084075A3 Adam-9 modulators |
| 06/28/2007 | WO2006081372A3 Use of parasitic biological agents for prevention and control of allergic and other ige-mediated disorders |
| 06/28/2007 | WO2006076003A3 Vaccinia virus strains |
| 06/28/2007 | WO2005113601A8 Antibodies and molecules derived therefrom that bind to steap-1 proteins |